Track lanreotide in Peptimes™
Lanreotide is a synthetic octapeptide with a biological activity similar to natural somatostatin. It is the active ingredient, as lanreotide acetate, in Somatuline Depot and generic lanreotide injections. (Source: DailyMed label.)
Is lanreotide FDA-approved?
Yes, as specific products: Somatuline Depot and a generic lanreotide injection are FDA-approved, by prescription, for the uses in their labels.
Lanreotide
Also: Somatuline Depot, Somatuline Autogel, lanreotide acetate, BIM 23014
- Status label in the Peptimes Library
- FDA Approved
- Routes in Peptimes
- Subcutaneous
- Updated
- 1 Nov 2026
US regulatory status
FDA approval belongs to each product below, for its route and the uses in its label. Label uses are shortened unless quoted.
Somatuline Depot (lanreotide) injection
Subcutaneous
Long-term treatment of acromegaly in the patients the label defines; adults with the gastroenteropancreatic neuroendocrine tumors (GEP-NETs) the label defines; and adults with carcinoid syndrome.
Source: DailyMed label, checked 1 Nov 2026
Generic lanreotide injection (Amneal), with Somatuline Depot as the reference product
Subcutaneous
As stated on its label (approved through an abbreviated new drug application, ANDA).
Source: Drugs@FDA, checked 1 Nov 2026
Investigational
No, for the products and uses above.
Source: Drugs@FDA, checked 1 Nov 2026
How to track it in Peptimes
Add lanreotide in My Protocols and set the schedule you already follow: days of the week, times of day and a start date. Peptimes never suggests an amount when you log or schedule a dose. Its Library entry shows the status label “FDA Approved”; the list above gives the detail by product.
- Logging: the amount you took and how you feel.
- Injection sites: each dose records the site, and Insights shows where you’ve injected and how recently. It never suggests where to inject next.
- Reminders and history: reminders at your times, Dose History, the Calendar and CSV or JSON export work as described on the peptide tracker app page.
Peptimes is a tracking app, not medical advice. Talk to a licensed clinician about your treatment. Peptimes doesn’t sell lanreotide or any other compound.
More sources
- FDA, Drugs@FDA, NDA 022074 (Somatuline Depot) and ANDA 218217 (generic lanreotide), checked 1 Nov 2026: product, route and marketing status.
- FDA, Global Substance Registration System, Lanreotide, checked 1 Nov 2026: the substance record and its names.
Related pages
Brand names on this page are trademarks of their owners. Peptimes isn't affiliated with or endorsed by them.